06 dec: SimCorps Finanskalender 2017
06 dec: Finanskalender 2017
06-12-2016 15:16:09

Chr. Hansen Holding A/S appoints new Chief Scientific Officer

Relateret indhold
21 jun - 
Torsdagens aktier: Novo mildnede tilbagegang for C25 ef..
21 jun - 
Aktier/middag: Novo styrker grønt C25 efter positive st..
21 jun - 
Chr. Hansen/UBS: Sænker anbefaling til "neutral" fra "k..
Relateret debat
09 jun - 
Har stadig mine købt i kurs 115 :-)
09 jun - 
Super Alpe, tak for hjælpen. Jeg holder fast i mine lid..
09 jun - 
Den er uændret stærk i optrend, med obs på at købssigna..

Hoersholm, 2016-12-06 15:16 CET (GLOBE NEWSWIRE) --

 

Company announcement No. 25/2016

Chr. Hansen Holding A/S has entered into an agreement with Thomas Schäfer to take up the position of Executive Vice President and Chief Scientific Officer.

Thomas is currently employed as Vice President at Novozymes and will take up his new position as soon as possible, which is expected to be during spring 2017.

A German national, Thomas completed his Ph.D. in Microbiology, Physiology & Biochemistry and worked as an assistant professor at Freie Universität Berlin. He started his commercial career as a post doc and has since 1994 held various senior leadership positions in the R&D space at Novozymes.

Thomas has more than 20 years’ experience in industrial microbiology, R&D, Innovation, business development and M&A, covering both bacteria and enzymes. He has published several papers, and is the co-founder of a number of patents.

Cees de Jong, CEO of Chr. Hansen, says: “I’m pleased to welcome Thomas to Chr. Hansen as we continue to strengthen our capabilities within the microbial platform and our leadership position in bacterial fermentation technology.”

Following this appointment, the Executive Board will consist of: CEO Cees de Jong, CFO Søren Westh Lonning, COO Knud Vindfeldt, and CSO Thomas Schäfer.

 

For further information, please contact:

Anders Mohr Christensen, Senior Director, Investor Relations

Tel: +45 4574 7618

Camilla Lercke, Head of Media Relations

Tel: +45 5339 2384

 

About Chr. Hansen

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2015/16 financial year was EUR 949 million. The company has more than 2,700 dedicated employees in 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on Nasdaq Copenhagen A/S. For further information, please visit www.chr-hansen.com.

Vedhæftet fil: No 25 2016 US.pdf

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Vind: Tyrkiet åbner op bud på 1,2 GW havvind

22-06-2018 12:08:41
Tyrkiet har lanceret landets første budrunde på havvindenergi og har allokeret en kapacitet på 1,2 gigawatt til formålet. Myndighederne har fastlagt et loft for budprisen på 80 dollar per megawatt-time, og interesserede selskaber og konsortier skal senest 23. oktober indlevere deres bud. Støtten vil blive givet i form af en elsalgsaftale for de første 50 terawatt-timer produceret energi, skriver R..

Unibrew/Danske: Kursmålet løftes til 525 kr.

22-06-2018 10:45:53
Royal Unibrews opjustering torsdag eftermiddag har fået Danske Bank til at løfte sit kursmål for bryggeriaktien til 520 kr. fra 475 kr. Anbefalingen er uændret "hold", viser data fra Bloomberg News.Unibrews nye prognose lyder på en omsætning mellem 6,8 og 7 mia. kr., et primært driftsresultat (EBITDA) på 1550 til 1625 mio. kr. og et driftsresultat efter af- og nedskrivninger på 1190 til 1265 mio. ..

Aktier/tendens: Unibrew kan ryge op i forventet rolig markedsåbning

22-06-2018 08:07:28
En opjustering fra Royal Unibrew bliver et af fokuspunkterne i fredagens tidlige danske aktiehandel, som generelt ser ud til at ville være præget af mindre bevægelser. Efter torsdagens danske børslukning, hvor det danske C25-indeks sluttede 0,2 pct. lavere i indeks 1119,14, var der ganske vist et lille fald i de amerikanske aktier på Wall Street. Men fredag morgen er der marginale plusser i handle..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Sagen om den manglende cent og quadrofobi

Relaterede aktiekurser

Chr Hansen Holding A/S 631,20 1,3% Stigning i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2018  Disclaimer  |  Cookie- og privatlivspolitik  |  Persondatapolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
23. juni 2018 21:45:50
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20180619.1 - EUROWEB5 - 2018-06-23 21:45:50 - 2018-06-23 21:45:50 - 1 - Website: OKAY